YU118389A - Derivatives of proponol amine and process for obtaining thereof - Google Patents

Derivatives of proponol amine and process for obtaining thereof

Info

Publication number
YU118389A
YU118389A YU01183/89A YU118389A YU118389A YU 118389 A YU118389 A YU 118389A YU 01183/89 A YU01183/89 A YU 01183/89A YU 118389 A YU118389 A YU 118389A YU 118389 A YU118389 A YU 118389A
Authority
YU
Yugoslavia
Prior art keywords
derivatives
proponol
amine
obtaining
propanolamides
Prior art date
Application number
YU01183/89A
Other languages
English (en)
Inventor
F Kienzle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of YU118389A publication Critical patent/YU118389A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Gyroscopes (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
YU01183/89A 1988-06-10 1989-06-08 Derivatives of proponol amine and process for obtaining thereof YU118389A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH224588 1988-06-10

Publications (1)

Publication Number Publication Date
YU118389A true YU118389A (en) 1991-06-30

Family

ID=4229254

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01183/89A YU118389A (en) 1988-06-10 1989-06-08 Derivatives of proponol amine and process for obtaining thereof

Country Status (20)

Country Link
US (1) US5045567A (fr)
EP (1) EP0345591B1 (fr)
JP (1) JPH0236158A (fr)
KR (1) KR910000600A (fr)
AT (1) ATE87610T1 (fr)
AU (1) AU622907B2 (fr)
DE (1) DE58903919D1 (fr)
DK (1) DK284289A (fr)
ES (1) ES2053866T3 (fr)
FI (1) FI892341A (fr)
HU (1) HUT55344A (fr)
IE (1) IE891855L (fr)
IL (1) IL90528A0 (fr)
MC (1) MC2042A1 (fr)
NO (1) NO170011C (fr)
NZ (1) NZ229456A (fr)
PH (1) PH26237A (fr)
PT (1) PT90802B (fr)
YU (1) YU118389A (fr)
ZA (1) ZA894210B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
EP0869121B1 (fr) * 1997-04-04 2004-06-09 Aventis Pharma Deutschland GmbH Dérivés de la propanolamine hypolipidémiques
DE19845403B4 (de) 1998-10-02 2005-02-10 Aventis Pharma Deutschland Gmbh Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112938A (fr) * 1970-09-30 1972-04-05
HU163935B (fr) * 1971-06-25 1973-11-28
CA1145767A (fr) * 1978-07-03 1983-05-03 Jack Mills Phenethanolamines, composes les contenant et methode pour maigrir
EP0070134B1 (fr) * 1981-07-11 1985-11-13 Beecham Group Plc Phényléthanolamines secondaires et leur emploi en pharmacie
CA1258454A (fr) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
WO1984000956A1 (fr) * 1982-08-27 1984-03-15 Beecham Group Plc Arylethanol amines secondaires
EP0139921B1 (fr) * 1983-08-17 1987-03-25 Beecham Group Plc Dérivés de 2-phényléthylamine
DE3466387D1 (en) * 1983-11-04 1987-10-29 Beecham Group Plc Tertiary amines
CA1249992A (fr) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
FR2588556B1 (fr) * 1985-10-11 1988-01-08 Sanofi Sa Derives du naphtalene substitues par un groupement (omega-amino) alcanol a activite antimicrobienne, leur preparation et les compositions les contenant
CA1287061C (fr) * 1986-06-27 1991-07-30 Roche Holding Ltd. Derives de pyridineethanolamines
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.

Also Published As

Publication number Publication date
KR910000600A (ko) 1991-01-29
DK284289A (da) 1989-12-11
NZ229456A (en) 1992-02-25
JPH0236158A (ja) 1990-02-06
IE891855L (en) 1989-12-10
EP0345591A1 (fr) 1989-12-13
ES2053866T3 (es) 1994-08-01
PH26237A (en) 1992-04-01
IL90528A0 (en) 1990-01-18
NO892387D0 (no) 1989-06-09
DK284289D0 (da) 1989-06-09
MC2042A1 (fr) 1990-05-30
FI892341A (fi) 1989-12-11
EP0345591B1 (fr) 1993-03-31
ATE87610T1 (de) 1993-04-15
ZA894210B (en) 1990-03-28
US5045567A (en) 1991-09-03
PT90802B (pt) 1994-11-30
NO170011C (no) 1992-09-02
FI892341A0 (fi) 1989-05-16
NO892387L (no) 1989-12-11
AU622907B2 (en) 1992-04-30
DE58903919D1 (en) 1993-05-06
NO170011B (no) 1992-05-25
AU3602689A (en) 1989-12-14
HUT55344A (en) 1991-05-28
PT90802A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
PT85184A (en) Process for the preparation of pyridine ethanolamine derivatives and of pharmaceutical compositions containing the same
DE69122099D1 (de) Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen
IE39095L (en) Feed additive for ruminants.
IL60530A (en) Animal feed compositions useful as growth promotors and for reduction of fat in animals,comprising phenylethanolamine derivatives and certain such novel compounds
HUT44173A (en) Process for producing veterinary compositions
DE3164944D1 (en) 3,4,5-trihydroxypiperidine derivatives, process for their preparation, their use as medicines and in animal feeding
YU118389A (en) Derivatives of proponol amine and process for obtaining thereof
IE880628L (en) Substituted pyridine-2,4-dicarboxylic acid derivatives,¹processes for their preparation, the use thereof and¹medicaments based on these compounds
ATE13131T1 (de) Neuer futterzusatz zur verbesserung des wachstums.
PH24504A (en) Pyridobenzodiazepinones,pharmaceutical compositions and method of use thereof
EP1103255A4 (fr) Procede de culture et aliments
KR890701028A (ko) 살코기 생산 동물에 대한 피롤리마이신 성장 향상제
ATE84194T1 (de) Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
AU4977290A (en) Method and apparatus for administering live bacteria as feed additives to livestock and poultry
UA22101A (uk) Кормова добавка для жуйних твариh